Share This Article:

A psychiatric whodunit: Serotonin syndrome in the emergency department

Abstract Full-Text HTML Download Download as PDF (Size:36KB) PP. 281-283
DOI: 10.4236/ojpsych.2012.24039    4,078 Downloads   5,728 Views  

ABSTRACT

Serotonin syndrome is a life-threatening reaction associated with serotonergic agents. Its mortality is estimated around 11%, hence prompt diagnosis is necessary [1]. Given the variability of its presentation, physicians often misdiagnose this devastating condition. We present a case of serotonin syndrome seen in the Emergency Department by an on-call psychiatric resident and review the Hunter Serotonin Toxicity Criteria, emphasizing the importance of physician familiarity with these criteria.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Rodgman, C. , Thompson, M. , Vergara, N. and Rodgman, C. (2012) A psychiatric whodunit: Serotonin syndrome in the emergency department. Open Journal of Psychiatry, 2, 281-283. doi: 10.4236/ojpsych.2012.24039.

References

[1] Mills, K.C. and Bora, K.M. (2011) A typical antidepressants, serotonin reuptake inhibitors, and serotonin syndrome. In: Tintinalli, J.E., Stapczynski, J.S., Cline, D.M., Ma, O.J., Cydulka, R.K. and Meckler, G.D., Eds., Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 7th Edition, McGraw-Hill, New York. http://www.accessmedicine.com/content.aspx?aID=6384959
[2] Nicoll, D., McPhee, S.J., Pignone, M., Lu and Chuanyi Mark, Pocket Guide to Diagnostic Tests: http://www.accessmedicine.com/pocketDiagnostic.aspx
[3] Gillman, P.K. (1999) The serotonin syndrome and its treatment. Journal of Psychopharmacology, 13, 100-109. doi:10.1177/026988119901300111
[4] Dunkley, E.J., Isbister, G.K., Sibbritt, D., Dawson, A.H., Whyte, I.M. (2003) The hunter serotonin toxicity criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM, 96, 635-642. doi:10.1093/qjmed/hcg109
[5] Gillman, K. (2010) Neuroleptic malignant syndrome: Mechanisms, interactions, and causality. Movement Disorders, 25, 1780-1790. doi:10.1002/mds.23220
[6] Adityanjee, M.T. and Aderibigbe Y. (1999) Proposed research diagnostic criteria for neuroleptic malignant syndrome. The International Journal of Neuropsychopharmacology, 2, 129-144. doi:10.1017/S1461145799001388
[7] Ables, A.Z. and Nagubilli, R. (2010) Prevention, recognition, and management of serotonin syndrome. American Family Physician, 81, 1139-1142.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.